Juan Carlos Ramirez, Chief Technology/Scientific Officer and Natalia Elizalde, Business Development Director, will be present at this event that will be hold in Berlin.

Please, do not hesitate to contact us to organize a meeting there so we will find a specific slot from the 6th to the 8th of November.

VIVEbiotech´s main interests are:

  • Meeting with Companies developing its own Gene Therapy pipeline that are looking for a flexible Company able to adapt to its requirements in terms of Lentiviral vector development and manufacture.
  • Meeting with Companies with interest in Lentisoma´s vector Technology (Non-integrative episomal lentiviral vector) to discuss about collaborative options.
  • Building a strong network allowing us to continue positioning as key players in viral vector manufacture field.